PURPOSE: Specific overexpression of cholecystokinin 2 (CCK2)/gastrin receptors has been demonstrated in several tumours of neuroendocrine origin. In some of these cancer types, such as medullary thyroid cancer (MTC), a sensitive diagnostic modality is still unavailable and therapeutic options for inoperable lesions are needed. Peptide receptor radionuclide therapy (PRRT) may be a viable therapeutic strategy in the management of these patients. Several CCK2R-targeted radiopharmaceuticals have been described in recent years. As part of the European Union COST Action BM0607 we studied the in vitro and in vivo characteristics of 12 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated CCK2R binding peptides. In the present study, we analysed binding and internalization characteristics. Stability, biodistribution and imaging studies have been performed in parallel by other centres involved in the project. METHODS: Determination of IC(50) values was performed using autoradiography, with DOTA-peptides displacing (125)I-CCK from receptors on tissue sections from human tumours. Saturation binding and internalization experiments were performed using (111)In-labelled peptides. The rat AR42J cell line and the human A431-CCK2R transfected cell line were utilized for in vitro experiments; dissociation constants (K(d)) and apparent number of binding sites (B(max)) were determined. Internalization was determined in receptor-expressing cells by incubating with tracer amounts of peptide at 37 and 4°C for different times up to 120 min. Surface-bound peptide was then stripped either by acid wash or subsequent incubation with 1 μM unlabelled peptide at 4°C. RESULTS: All peptides showed high receptor affinity with IC(50) values ranging from 0.2 to 3.4 nM. Saturation experiments also showed high affinity with K(d) values in the 10(-9)-10(-8) M range. B(max) values estimated in A431-CCK2R cells ranged from 0.6 to 2.2 × 10(6) per cell. All peptides showed high levels of internalization when incubated at 37°C. CONCLUSION: All DOTA-conjugated peptides showed high receptor binding and internalization properties and appear suitable for further characterization, as described in other articles of this issue.
PURPOSE: Specific overexpression of cholecystokinin 2 (CCK2)/gastrin receptors has been demonstrated in several tumours of neuroendocrine origin. In some of these cancer types, such as medullary thyroid cancer (MTC), a sensitive diagnostic modality is still unavailable and therapeutic options for inoperable lesions are needed. Peptide receptor radionuclide therapy (PRRT) may be a viable therapeutic strategy in the management of these patients. Several CCK2R-targeted radiopharmaceuticals have been described in recent years. As part of the European Union COST Action BM0607 we studied the in vitro and in vivo characteristics of 12 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated CCK2R binding peptides. In the present study, we analysed binding and internalization characteristics. Stability, biodistribution and imaging studies have been performed in parallel by other centres involved in the project. METHODS: Determination of IC(50) values was performed using autoradiography, with DOTA-peptides displacing (125)I-CCK from receptors on tissue sections from humantumours. Saturation binding and internalization experiments were performed using (111)In-labelled peptides. The rat AR42J cell line and the human A431-CCK2R transfected cell line were utilized for in vitro experiments; dissociation constants (K(d)) and apparent number of binding sites (B(max)) were determined. Internalization was determined in receptor-expressing cells by incubating with tracer amounts of peptide at 37 and 4°C for different times up to 120 min. Surface-bound peptide was then stripped either by acid wash or subsequent incubation with 1 μM unlabelled peptide at 4°C. RESULTS: All peptides showed high receptor affinity with IC(50) values ranging from 0.2 to 3.4 nM. Saturation experiments also showed high affinity with K(d) values in the 10(-9)-10(-8) M range. B(max) values estimated in A431-CCK2R cells ranged from 0.6 to 2.2 × 10(6) per cell. All peptides showed high levels of internalization when incubated at 37°C. CONCLUSION: All DOTA-conjugated peptides showed high receptor binding and internalization properties and appear suitable for further characterization, as described in other articles of this issue.
Authors: Berthold A Nock; Theodosia Maina; Martin Béhé; Anastasia Nikolopoulou; Martin Gotthardt; Jörg S Schmitt; Thomas M Behr; Helmut R Mäcke Journal: J Nucl Med Date: 2005-10 Impact factor: 10.057
Authors: Susan Roosenburg; Peter Laverman; Lieke Joosten; Annemarie Eek; Wim J G Oyen; Marion de Jong; Floris P J T Rutjes; Floris L van Delft; Otto C Boerman Journal: Bioconjug Chem Date: 2010-04-21 Impact factor: 4.774
Authors: Meltem Ocak; Anna Helbok; Christine Rangger; Petra Kolenc Peitl; Berthold A Nock; Giancarlo Morelli; Annemarie Eek; Jane K Sosabowski; Wout A P Breeman; Jean Claude Reubi; Clemens Decristoforo Journal: Eur J Nucl Med Mol Imaging Date: 2011-04-29 Impact factor: 9.236
Authors: Elisabeth von Guggenberg; Werner Sallegger; Anna Helbok; Meltem Ocak; Robert King; Stephen J Mather; Clemens Decristoforo Journal: J Med Chem Date: 2009-08-13 Impact factor: 7.446
Authors: Martin Béhé; Wolfgang Becker; Martin Gotthardt; Christa Angerstein; Thomas M Behr Journal: Eur J Nucl Med Mol Imaging Date: 2003-05-24 Impact factor: 9.236
Authors: Jane K Sosabowski; Torkjel Matzow; Julie M Foster; Ciara Finucane; David Ellison; Susan A Watson; Stephen J Mather Journal: J Nucl Med Date: 2009-11-12 Impact factor: 10.057
Authors: Peter Laverman; Susan Roosenburg; Martin Gotthardt; Jeseong Park; Wim J G Oyen; Marion de Jong; Mark R Hellmich; Floris P J T Rutjes; Floris L van Delft; Otto C Boerman Journal: Eur J Nucl Med Mol Imaging Date: 2007-10-13 Impact factor: 9.236
Authors: E von Guggenberg; H Dietrich; I Skvortsova; M Gabriel; I J Virgolini; C Decristoforo Journal: Eur J Nucl Med Mol Imaging Date: 2007-02-17 Impact factor: 10.057
Authors: Joachim Pfister; Dominik Summer; Christine Rangger; Milos Petrik; Elisabeth von Guggenberg; Paolo Minazzi; Giovanni B Giovenzana; Luigi Aloj; Clemens Decristoforo Journal: EJNMMI Res Date: 2015-12-15 Impact factor: 3.138